A case of secondary IgA nephropathy accompanied by psoriasis treated with secukinumab-Reference-Cited by-同舟云学术

A case of secondary IgA nephropathy accompanied by psoriasis treated with secukinumab

Published:2019-04-03 Issue:3 Volume:8 Page:200-204
ISSN:2192-4449
Container-title:CEN Case Reports
language:en
Short-container-title:CEN Case Rep

Author:

Ochi Masahiko,Toyama Tadashi^ORCID,Ando Mai,Sato Koichi,Kamikawa Yasutaka,Sagara Akihiro,Kitajima Shinji,Hara Akinori,Iwata Yasunori,Sakai Norihiko,Shimizu Miho,Furuichi Kengo,Hamaguchi Yasuhito,Kaneko Shuichi,Wada Takashi

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

http://link.springer.com/content/pdf/10.1007/s13730-019-00393-5.pdf

Reference14 articles.

1. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496–509.

2. Wan J, Wang S, Haynes K, Denburg MR, Shin DB, Gelfand JM. Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ. 2013;347:f5961.

3. Chiu HY, Huang HL, Li CH, Yin YJ, Chen HA, Hsu ST, et al. Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study. Br J Dermatol. 2015;173(1):146–54.

4. Pouria S, Barratt J. Secondary IgA nephropathy. Semin Nephrol. 2008;28(1):27–37.

5. Bagel J, Duffin KC, Moore A, Ferris LK, Siu K, Steadman J, et al. The effect of secukinumab on moderate-to-severe scalp psoriasis: results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study. J Am Acad Dermatol. 2017;77:667–74.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal relationship between inflammatory skin diseases and immunoglobulin A nephropathy: A Mendelian randomization and enrichment analysis study;Skin Research and Technology;2024-08

2. Advancements in understanding the role of intestinal dysbacteriosis mediated mucosal immunity in IgA nephropathy;BMC Nephrology;2024-06-21

3. Th17 cells: A new target in kidney disease research;International Reviews of Immunology;2024-03-05

4. Sequential administration of paricalcitol followed by IL-17 blockade for progressive refractory IgA nephropathy patients;Scientific Reports;2024-02-28

5. A case of psoriasis with IgA nephropathy successfully treated with secukinumab;International Journal of Dermatology;2023-11-11